DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA612726
Title:
Role of IKK-alpha in the EGFR Signaling Regulation
Descriptive Note:
Annual summary rept. 15 Aug 2010 - 14 Aug 2014
Corporate Author:
M D ANDERSON CANCER CENTER HOUSTON TX
Report Date:
2014-09-01
Pagination or Media Count:
69.0
Abstract:
Overexpression of EGFR is frequently linked to more aggressive tumor behavior, including increased proliferation, metastasis, and therapeutic resistance. Here, we identified a molecular linkage between IKKalpha and EGFR signaling in breast cancer cells. Inhibition of IKKs activity elevates EGFR tyrosine phosphorylation. In addition, IKKalpha forms a specific interaction with EGFR in Golgi apparatus and catalyzes EGFR S1026 phosphorylation. We found that EGFR S1026A possess a stronger tumorgenesis phenotype compare with wild type EGFR suggesting a negative regulation of IKKalpha in EGFR signaling. In agreement with an earlier finding where conditional ablation of IKKalpha in the mice keratinocytes elevates the autocrine loop of EGFR, our results further provide a potent role of IKKalpha kinase activity in preservation of EGFR activity.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE